Cardiovascular Disease Archives - Page 107 of 108 - Clinical Advisor

Cardiovascular Disease

Angiogram of an MI (left) and a normal coronary artery (right)

COPD drugs linked to risk of CV events

Inhaled anticholinergic agents, the most common treatment for chronic obstructive pulmonary disease (COPD), may increase the risk of cardiovascular (CV) events by 58%.

Thyrotropin linked to fatal CHD risks in women

Women’s risk of fatal coronary heart disease (CHD) rises with levels of thyrotropin, a hormone that stimulates thyroid function— even when those levels are within the normal range, a recent study suggests…

B vitamins fail to cut CV risk

Evidence continues to mount showing that additional folic acid and B vitamin have no effect on the probability of cardiovascular (CV) events, even among high-risk women…

Creatinine increase after ACE inhibitor

Two readers ask about rising creatinine levels following ACE inhibitor therapy: At what serum creatinine level should discontinuation of an ACE inhibitor or angiotensin receptor blocker be implemented? Is the recommendation different for a patient with diabetes vs. a patient without?—Regina A. Roman, DO, Murrells Inlet, S.C. How long does it take for the creatinine…

Cardiac parameters at odds

When evaluating a patient’s risk of vascular disease, primary-care clinicians often use the cholesterol/HDL ratio, while cardiologists use the LDL level. What should one do if the cholesterol/HDL ratio is favorable, but the LDL is high?—Melvin L. Edwards, MD, Ann Arbor, Mich. The usual reason the ratio is favorable is that the HDL is high.…

Next post in Advisor Forum